Back to Journals » Cancer Management and Research » Volume 10

Low-dose eribulin mesylate exerts antitumor effects in gastric cancer by inhibiting fibrosis via the suppression of epithelial–mesenchymal transition and acts synergistically with 5-fluorouracil

Total article views   HTML views PDF downloads Totals
7,668 Dovepress* 6,852+ 798 7,650
PubMed Central* 816 240 1,056
Totals 7,668 1,038 8,706
*Since 15 August 2018
Total mentioned Facebook Delicious Reddit Twitter Others
7 0 0 0 3 4

View citations on PubMed Central and Google Scholar